Skip to content
Enea Tech Biomedica logo
News Press
16/12/2024

ENEA-Tech Biomedical Foundation Invests €6m in BetaGlue® Therapeutics Bringing 2024 Funding Round Total to €24m

Colin Story - BetaGlue
News Press
06/06/2024

BetaGlue® Adds €8m Equity Financing to €10m EIC Accelerator Award

New Betaglue board members
News Press
15/05/2024

BetaGlue® Therapeutics Announces the Appointment of Mike Cogswell as Chairman and Mike Maszy as Non-Executive Director

Website Launch
News Press
30/04/2024

BetaGlue® Technologies SpA Announces Rebrand & Introduces YntraDose®

EU Logo
News Press
04/03/2024

BetaGlue® Secures €10m EIC Accelerator Award

Salvatore Calabrese CFO, BetaGlue
News Press
15/01/2024

BetaGlue® Appoints Salvatore Calabrese as Chief Financial Officer

Colin Story - BetaGlue
News Press
27/02/2023

BetaGlue® renews the BoD: Dr Colin Story appointed CEO

News
20/10/2022

BetaGlue® strengthens its expertise in strategic areas with four new managers

In Vivo
News
03/10/2022

BetaGlue® published an article on the performance and safety of BAT-90 on ‘In Vivo’

News
28/07/2022

BetaGlue® has closed a 10 million euro equity financing round